Denali Therapeutics Inc (DNLI)
EBITDA Margin
-13823.72%
TTM · Period ending:
DNLI EBITDA Margin
Latest reported-13823.72%period ending
Latest reported-13823.72%period ending
DNLI TTM EBITDA Margin (-14187.05% → -13823.72%)
TTM ebitda margin
High-resolution chart · PNG
DNLI ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -13,823.7236% | |
| -34,852.0916% | |
| -53.7676% | |
| -38.8672% | |
| -31.0419% | |
| -32.0067% | |
| -347.1019% | |
| -290.9628% | |
| -266.2619% | |
| -245.4892% | |
| -335.1525% | |
| -583.0994% | |
| 10.2558% | |
| 16.9827% | |
| 17.6467% | |
| 21.2266% | |
| -980.8343% | |
| -796.9055% | |
| -854.9526% | |
| -769.1469% | |
| -49.0168% | |
| -44.1781% | |
| -40.8125% | |
| -30.1618% | |
| -3,983.6682% | |
| -5,446.2211% | |
| -14,187.0515% |